[New Onset of Graves' Orbitopathy Following Bendamustine-Rituximab (BR) therapy in a Patient with Chronic Lymphocytic Leukemia: A Case Report and Literature Review].

Kozlov ED, Bessmertnaya EG, Chandola SS, Yamashkina EI

Open source

DOI
10.14341/probl13616
Published
2026 May 20
Container
Problemy endokrinologii
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.14341/probl13616,
  title = {[New Onset of Graves' Orbitopathy Following Bendamustine-Rituximab (BR) therapy in a Patient with Chronic Lymphocytic Leukemia: A Case Report and Literature Review].},
  author = {Kozlov ED and Bessmertnaya EG and Chandola SS and Yamashkina EI},
  year = {2026},
  journal = {Problemy endokrinologii},
  doi = {10.14341/probl13616},
  url = {https://doi.org/10.14341/probl13616}
}

RIS

TY  - JOUR
TI  - [New Onset of Graves' Orbitopathy Following Bendamustine-Rituximab (BR) therapy in a Patient with Chronic Lymphocytic Leukemia: A Case Report and Literature Review].
AU  - Kozlov ED
AU  - Bessmertnaya EG
AU  - Chandola SS
AU  - Yamashkina EI
PY  - 2026
JO  - Problemy endokrinologii
DO  - 10.14341/probl13616
UR  - https://doi.org/10.14341/probl13616
ER  - 

APA

ED, K., EG, B., SS, C., & EI, Y. (2026). [New Onset of Graves' Orbitopathy Following Bendamustine-Rituximab (BR) therapy in a Patient with Chronic Lymphocytic Leukemia: A Case Report and Literature Review].. Problemy endokrinologii. https://doi.org/10.14341/probl13616

Source records